Stock MEDICO MEDICO REMEDIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medico Remedies Limited

Equities

MEDICO

INE630Y01024

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:47 2024-05-14 am EDT 		5-day change 1st Jan Change
38.36 INR -4.98% Intraday chart for Medico Remedies Limited -15.26% -54.11%
May. 09 Medico Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
May. 09 Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 402.5 352.7 303.9 414.9 1,394 6,199
Enterprise Value (EV) 1 520 481.7 428.6 526.6 1,477 6,275
P/E ratio 26.6 x 22.5 x 18.6 x 16 x 28.5 x 85.6 x
Yield - - - - - -
Capitalization / Revenue 0.66 x 0.36 x 0.34 x 0.34 x 1.15 x 4.41 x
EV / Revenue 0.85 x 0.49 x 0.48 x 0.43 x 1.22 x 4.47 x
EV / EBITDA 14 x 14.1 x 15 x 10.1 x 20.4 x 68.2 x
EV / FCF -73.7 x -82.6 x -38.7 x -32.4 x 170 x -337 x
FCF Yield -1.36% -1.21% -2.58% -3.09% 0.59% -0.3%
Price to Book 1.51 x 1.25 x 1.02 x 1.28 x 3.74 x 14.1 x
Nbr of stocks (in thousands) 82,984 82,984 82,984 82,984 82,984 82,984
Reference price 2 4.850 4.250 3.662 5.000 16.80 74.70
Announcement Date 10/17/18 9/4/19 9/4/20 9/8/21 8/29/22 7/21/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 610.2 976.9 886.4 1,224 1,210 1,404
EBITDA 1 37.01 34.17 28.5 52.28 72.5 92.06
EBIT 1 26.97 19.05 11.87 35.77 51.7 69.01
Operating Margin 4.42% 1.95% 1.34% 2.92% 4.27% 4.91%
Earnings before Tax (EBT) 1 18.73 21.75 22.15 36.86 65.5 101
Net income 1 12.2 15.7 16.3 25.92 48.9 72.42
Net margin 2% 1.61% 1.84% 2.12% 4.04% 5.16%
EPS 2 0.1823 0.1890 0.1965 0.3123 0.5893 0.8726
Free Cash Flow 1 -7.057 -5.831 -11.07 -16.27 8.7 -18.61
FCF margin -1.16% -0.6% -1.25% -1.33% 0.72% -1.32%
FCF Conversion (EBITDA) - - - - 12% -
FCF Conversion (Net income) - - - - 17.79% -
Dividend per Share - - - - - -
Announcement Date 10/17/18 9/4/19 9/4/20 9/8/21 8/29/22 7/21/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 118 129 125 112 82.7 75.8
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.175 x 3.777 x 4.375 x 2.136 x 1.141 x 0.8239 x
Free Cash Flow 1 -7.06 -5.83 -11.1 -16.3 8.7 -18.6
ROE (net income / shareholders' equity) 5.67% 5.72% 5.61% 8.32% 14% 18%
ROA (Net income/ Total Assets) 3.13% 1.75% 0.98% 2.96% 4.26% 5.23%
Assets 1 390.2 894.7 1,666 874.7 1,149 1,384
Book Value Per Share 2 3.210 3.400 3.600 3.910 4.500 5.280
Cash Flow per Share 2 0.1000 0.0700 0.1700 0.3400 0.2800 0.2600
Capex 1 24 36.8 33.3 21.4 28.6 65.9
Capex / Sales 3.93% 3.77% 3.76% 1.75% 2.36% 4.69%
Announcement Date 10/17/18 9/4/19 9/4/20 9/8/21 8/29/22 7/21/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
MEDICO REMEDIES LIMITED Stock Medico Remedies Limited
-54.11% 40.11M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.06% 682B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.35% 586B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.42% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.02% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.27% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.53% 240B
NOVARTIS AG Stock Novartis AG
+10.16% 209B
ROCHE HOLDING AG Stock Roche Holding AG
-8.14% 203B
AMGEN INC. Stock Amgen Inc.
+8.12% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MEDICO Stock
  4. Financials Medico Remedies Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW